scispace - formally typeset
Search or ask a question
Institution

Case Western Reserve University

EducationCleveland, Ohio, United States
About: Case Western Reserve University is a education organization based out in Cleveland, Ohio, United States. It is known for research contribution in the topics: Population & Cancer. The organization has 54617 authors who have published 106568 publications receiving 5071613 citations. The organization is also known as: Case & Case Western.


Papers
More filters
Journal ArticleDOI
TL;DR: In this paper, the authors presented an analytic description of the complex transfer function superior to that given by minimization of the "weighted" sum of the squares of the errors in magnitude.
Abstract: Experimental frequency response data obtained from a linear dynamic system is processed to obtain the transfer function as a ratio of two frequency-dependent polynomials. The difference between the absolute magnitudes of the actual function and the polynomial ratio is the error considered. The polynomial coefficients are evaluated as the result of minimizing the sum of the squares of the above errors at the experimental points. The polynomial coefficients are computed numerically using an IBM 704 FORTRAN program. The magnitude and phase angle of the transfer function are evaluated at the various frequencies, using the computed polynomial ratio; and are compared with the observed data. The method presented here gives an analytic description of the complex transfer function superior to that given by minimization of the "weighted" sum of the squares of the errors in magnitude.

683 citations

Journal ArticleDOI
TL;DR: A broad framework is provided for incorporating AI and machine learning tools into clinical oncology, with an emphasis on biomarker development, and some of the challenges relating to the use of AI are discussed, including the need for well-curated validation datasets, regulatory approval and fair reimbursement strategies.
Abstract: In the past decade, advances in precision oncology have resulted in an increased demand for predictive assays that enable the selection and stratification of patients for treatment. The enormous divergence of signalling and transcriptional networks mediating the crosstalk between cancer, stromal and immune cells complicates the development of functionally relevant biomarkers based on a single gene or protein. However, the result of these complex processes can be uniquely captured in the morphometric features of stained tissue specimens. The possibility of digitizing whole-slide images of tissue has led to the advent of artificial intelligence (AI) and machine learning tools in digital pathology, which enable mining of subvisual morphometric phenotypes and might, ultimately, improve patient management. In this Perspective, we critically evaluate various AI-based computational approaches for digital pathology, focusing on deep neural networks and 'hand-crafted' feature-based methodologies. We aim to provide a broad framework for incorporating AI and machine learning tools into clinical oncology, with an emphasis on biomarker development. We discuss some of the challenges relating to the use of AI, including the need for well-curated validation datasets, regulatory approval and fair reimbursement strategies. Finally, we present potential future opportunities for precision oncology.

683 citations

Journal ArticleDOI
TL;DR: The identification of a cytokine expression profile under standardized growth medium conditions and in the presence of regulators of the osteogenic and stromal cell lineages is interpreted to suggest that mesenchymal progenitor cells derived from human bone marrow serve specific supportive functions in the microenvironment of bone marrow.
Abstract: We previously reported the purification, culture-expansion, and osteogenic differentiation potential of mesenchymal progenitor cells (MPCs) derived from human bone marrow. As a first step to establishing the phenotypic characteristics of MPCs, we reported on the identification of unique cell surface proteins which were detected with monoclonal antibodies. In this study, the phenotypic characterization of human marrow-derived MPCs is further established through the identification of a cytokine expression profile under standardized growth medium conditions and in the presence of regulators of the osteogenic and stromal cell lineages, dexamethasone and interleukin-1 alpha (IL-1 alpha), respectively. Constitutively expressed cytokines in this growth phase include G-CSF, SCF, LIF, M-CSF, IL-6, and IL-11, while GM-CSF, IL-3, TGF-beta 2 and OSM were not detected in the growth medium. Exposure of cells in growth medium to dexamethasone resulted in a decrease in the expression of LIF, IL-6, and IL-11. These cytokines have been reported to exert influence on the differentiation of cells derived from the bone marrow stroma through target cell receptors that utilize gp130-associated signal transduction pathways. Dexamethasone had no effect on the other cytokines expressed under growth medium conditions and was not observed to increase the expression of any of the cytokines measured in this study. In contrast, IL-1 alpha increased the expression of G-CSF, M-CSF, LIF, IL-6 and IL-11 and induced the expression of GM-CSF. IL-1 alpha had no effect on SCF expression and was not observed to decrease the production of any of the cytokines assayed. These data indicate that MPCs exhibit a distinct cytokine expression profile. We interpret this cytokine profile to suggest that MPCs serve specific supportive functions in the microenvironment of bone marrow. MPCs provide inductive and regulatory information which are consistent with the ability to support hematopoiesis, and also supply autocrine, paracrine, and juxtacrine factors that influence the cells of the marrow microenvironment itself. In addition, the cytokine profiles expressed by MPCs, in response to dexamethasone and IL-1 alpha, identify specific cytokines whose levels of expression change as MPCs differentiate or modulate their phenotype during osteogenic or stromagenic lineage entrance/progression.

682 citations

Journal ArticleDOI
TL;DR: A highly efficient drug vector for photodynamic therapy (PDT) drug delivery was developed by synthesizing PEGylated gold nanoparticle conjugates, which act as a water-soluble and biocompatible "cage" that allows delivery of a hydrophobic drug to its site of PDT action as discussed by the authors.
Abstract: A highly efficient drug vector for photodynamic therapy (PDT) drug delivery was developed by synthesizing PEGylated gold nanoparticle conjugates, which act as a water-soluble and biocompatible "cage" that allows delivery of a hydrophobic drug to its site of PDT action. The dynamics of drug release in vitro in a two-phase solution system and in vivo in cancer-bearing mice indicates that the process of drug delivery is highly efficient, and passive targeting prefers the tumor site. With the Au NP-Pc 4 conjugates, the drug delivery time required for PDT has been greatly reduced to less than 2 h, compared to 2 days for the free drug.

682 citations

Journal ArticleDOI
TL;DR: Diblock copolymers of poly(e-caprolactone) (PCL) and monomethoxy poly(ethylene glycol) (MPEG) with various compositions were synthesized and exhibited time-delayed cytotoxicity in human MCF-7 breast cancer cells.

681 citations


Authors

Showing all 54953 results

NameH-indexPapersCitations
Robert Langer2812324326306
Bert Vogelstein247757332094
Zhong Lin Wang2452529259003
John Q. Trojanowski2261467213948
Kenneth W. Kinzler215640243944
Peter Libby211932182724
David Baltimore203876162955
Carlo M. Croce1981135189007
Ronald Klein1941305149140
Eric J. Topol1931373151025
Paul M. Thompson1832271146736
Yusuke Nakamura1792076160313
Dennis J. Selkoe177607145825
David L. Kaplan1771944146082
Evan E. Eichler170567150409
Network Information
Related Institutions (5)
University of Pennsylvania
257.6K papers, 14.1M citations

97% related

Johns Hopkins University
249.2K papers, 14M citations

97% related

Yale University
220.6K papers, 12.8M citations

96% related

Columbia University
224K papers, 12.8M citations

96% related

Harvard University
530.3K papers, 38.1M citations

96% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023142
2022411
20214,338
20204,141
20193,978
20183,663